4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide

C165H172BrF9N20O32 — CID 161330955

About 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide

4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide (PubChem CID 161330955) has the molecular formula C165H172BrF9N20O32 and a molecular weight of 3198.18 g/mol. Its IUPAC name is 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide.

Molecular Properties

• Compound Name: 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide
• PubChem CID: 161330955
• Molecular Formula: C165H172BrF9N20O32
• Molecular Weight: 3198.18 g/mol
• Exact Mass: 3195.15
• IUPAC Name: 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide
• SMILES: CC(NC(=O)C(O)C(O)C(=O)N1CCC2Nc3ccccc3C2C1)c1ccc(Br)cc1.CNC(=O)[C@H](O)[C@@H](O)C(=O)N1CCN(c2cccc3ccccc23)CC1.CNC(=O)[C@H](O)[C@@H](O)C(=O)Nc1ccc(-c2ccc(C(F)(F)F)cc2)cc1.CNC(=O)[C@H](O)[C@@H](O)C(=O)Nc1ccc(-c2ccccc2)cc1.CNC(=O)[C@H](O)[C@@H](O)C(=O)Nc1ccc(C#Cc2ccccc2)cc1.CNC(=O)[C@H](O)[C@@H](O)C(=O)n1ccc2cc(C#Cc3ccccc3)ccc21.C[C@H](NC(=O)C(O)C(O)C(=O)N1CCc2ccccc2C1)c1ccc(C(F)(F)F)cc1.O=C(NCCCCCn1c(C(F)(F)F)nc2ccccc21)C(O)C(O)C(=O)N1CCc2ccccc2C1
• InChI: InChI=1S/C26H29F3N4O4.C23H26BrN3O4.C22H23F3N2O4.C21H18N2O4.C19H23N3O4.C19H18N2O4.C18H17F3N2O4.C17H18N2O4/c27-26(28,29)25-31-19-10-4-5-11-20(19)33(25)14-7-1-6-13-30-23(36)21(34)22(35)24(37)32-15-12-17-8-2-3-9-18(17)16-32;1-13(14-6-8-15(24)9-7-14)25-22(30)20(28)21(29)23(31)27-11-10-19-17(12-27)16-4-2-3-5-18(16)26-19;1-13(14-6-8-17(9-7-14)22(23,24)25)26-20(30)18(28)19(29)21(31)27-11-10-15-4-2-3-5-16(15)12-27;1-22-20(26)18(24)19(25)21(27)23-12-11-16-13-15(9-10-17(16)23)8-7-14-5-3-2-4-6-14;1-20-18(25)16(23)17(24)19(26)22-11-9-21(10-12-22)15-8-4-6-13-5-2-3-7-14(13)15;1-20-18(24)16(22)17(23)19(25)21-15-11-9-14(10-12-15)8-7-13-5-3-2-4-6-13;1-22-16(26)14(24)15(25)17(27)23-13-8-4-11(5-9-13)10-2-6-12(7-3-10)18(19,20)21;1-18-16(22)14(20)15(21)17(23)19-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-5,8-11,21-22,34-35H,1,6-7,12-16H2,(H,30,36);2-9,13,17,19-21,26,28-29H,10-12H2,1H3,(H,25,30);2-9,13,18-19,28-29H,10-12H2,1H3,(H,26,30);2-6,9-13,18-19,24-25H,1H3,(H,22,26);2-8,16-17,23-24H,9-12H2,1H3,(H,20,25);2-6,9-12,16-17,22-23H,1H3,(H,20,24)(H,21,25);2-9,14-15,24-25H,1H3,(H,22,26)(H,23,27);2-10,14-15,20-21H,1H3,(H,18,22)(H,19,23)/t;;13-,18?,19?;18-,19-;2*16-,17-;2*14-,15-/m..011111/s1
• InChIKey: VLKGMHOGHSFXDP-RABSPELYSA-N
• XLogP: 11.13
• TPSA: 780.11 Ų
• H-Bond Donors: 28
• H-Bond Acceptors: 37
• Rotatable Bonds: 40
• Heavy Atoms: 227
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3198.18
LogP ≤ 5	11.13
H-Bond Donors ≤ 5	28
H-Bond Acceptors ≤ 10	37

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide?

The IUPAC name of 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide (CID 161330955) is 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide.

What is the SMILES notation for 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide?

The canonical SMILES for 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide is CC(NC(=O)C(O)C(O)C(=O)N1CCC2Nc3ccccc3C2C1)c1ccc(Br)cc1.CNC(=O)[C@H](O)[C@@H](O)C(=O)N1CCN(c2cccc3ccccc23)CC1.CNC(=O)[C@H](O)[C@@H](O)C(=O)Nc1ccc(-c2ccc(C(F)(F)F)cc2)cc1.CNC(=O)[C@H](O)[C@@H](O)C(=O)Nc1ccc(-c2ccccc2)cc1.CNC(=O)[C@H](O)[C@@H](O)C(=O)Nc1ccc(C#Cc2ccccc2)cc1.CNC(=O)[C@H](O)[C@@H](O)C(=O)n1ccc2cc(C#Cc3ccccc3)ccc21.C[C@H](NC(=O)C(O)C(O)C(=O)N1CCc2ccccc2C1)c1ccc(C(F)(F)F)cc1.O=C(NCCCCCn1c(C(F)(F)F)nc2ccccc21)C(O)C(O)C(=O)N1CCc2ccccc2C1.

What is the InChIKey of 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide?

The InChIKey is VLKGMHOGHSFXDP-RABSPELYSA-N. The full InChI is InChI=1S/C26H29F3N4O4.C23H26BrN3O4.C22H23F3N2O4.C21H18N2O4.C19H23N3O4.C19H18N2O4.C18H17F3N2O4.C17H18N2O4/c27-26(28,29)25-31-19-10-4-5-11-20(19)33(25)14-7-1-6-13-30-23(36)21(34)22(35)24(37)32-15-12-17-8-2-3-9-18(17)16-32;1-13(14-6-8-15(24)9-7-14)25-22(30)20(28)21(29)23(31)27-11-10-19-17(12-27)16-4-2-3-5-18(16)26-19;1-13(14-6-8-17(9-7-14)22(23,24)25)26-20(30)18(28)19(29)21(31)27-11-10-15-4-2-3-5-16(15)12-27;1-22-20(26)18(24)19(25)21(27)23-12-11-16-13-15(9-10-17(16)23)8-7-14-5-3-2-4-6-14;1-20-18(25)16(23)17(24)19(26)22-11-9-21(10-12-22)15-8-4-6-13-5-2-3-7-14(13)15;1-20-18(24)16(22)17(23)19(25)21-15-11-9-14(10-12-15)8-7-13-5-3-2-4-6-13;1-22-16(26)14(24)15(25)17(27)23-13-8-4-11(5-9-13)10-2-6-12(7-3-10)18(19,20)21;1-18-16(22)14(20)15(21)17(23)19-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-5,8-11,21-22,34-35H,1,6-7,12-16H2,(H,30,36);2-9,13,17,19-21,26,28-29H,10-12H2,1H3,(H,25,30);2-9,13,18-19,28-29H,10-12H2,1H3,(H,26,30);2-6,9-13,18-19,24-25H,1H3,(H,22,26);2-8,16-17,23-24H,9-12H2,1H3,(H,20,25);2-6,9-12,16-17,22-23H,1H3,(H,20,24)(H,21,25);2-9,14-15,24-25H,1H3,(H,22,26)(H,23,27);2-10,14-15,20-21H,1H3,(H,18,22)(H,19,23)/t;;13-,18?,19?;18-,19-;2*16-,17-;2*14-,15-/m..011111/s1.

What are the key properties of 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide?

4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide has a molecular weight of 3198.18 g/mol, XLogP of 11.13, 40 rotatable bonds, 28 hydrogen bond donors, and 37 hydrogen bond acceptors.

Where does this data come from?

All data for 4-(1,3,4,4a,5,9b-hexahydropyrido[4,3-b]indol-2-yl)-N-[1-(4-bromophenyl)ethyl]-2,3-dihydroxy-4-oxobutanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[5-[2-(trifluoromethyl)benzimidazol-1-yl]pentyl]butanamide;4-(3,4-dihydro-1H-isoquinolin-2-yl)-2,3-dihydroxy-4-oxo-N-[(1S)-1-[4-(trifluoromethyl)phenyl]ethyl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-(4-naphthalen-1-ylpiperazin-1-yl)-4-oxobutanamide;(2R,3R)-2,3-dihydroxy-N-methyl-4-oxo-4-[5-(2-phenylethynyl)indol-1-yl]butanamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-(2-phenylethynyl)phenyl]butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-(4-phenylphenyl)butanediamide;(2R,3R)-2,3-dihydroxy-N-methyl-N'-[4-[4-(trifluoromethyl)phenyl]phenyl]butanediamide is sourced from PubChem (CID 161330955), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).